Position in UTHR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$37,360,703
-$6,942,502 QoQ
Shares Held
63,005
-30.7% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Derivatives in UTHR
reported options exposure · as of Mar 31, 2021CallValue
$0
CallShares
0
PutValue
$5,603,545
PutShares
33,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $516,666,064 across 52 Drug Manufacturers - Specialty & Generic names. UTHR ranks #5 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,809,925 | $213,951,231 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,745,751 | $53,210,488 | |
| 3 | VTRS |
Viatris Inc
|
3,144,439 | $42,481,369 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,400,671 | $42,188,210 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
63,005 | $37,360,703 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
243,984 | $32,142,450 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
971,854 | $13,508,770 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
639,372 | $13,273,362 |
All Filings in UTHR
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,360,703 | 63,005 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $44,303,205 | 90,925 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $32,976,284 | 114,760 | Shares | Sole | 2026-02-27 | |
| 2022-09-30 | $12,341,272 | 58,942 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $4,498,837 | 19,092 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,573,128 | 19,916 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,256,325 | 15,070 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $11,144,571 | 60,378 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $7,197,749 | 40,119 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,781,030 | 16,626 | Shares | Sole | 2021-05-13 | |
| 2021-03-31 | $5,603,545 | 33,500 | Put | Sole | 2021-05-13 | |
| 2020-12-31 | $1,069,664 | 7,047 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $990,103 | 9,803 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,915,430 | 15,830 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $3,688,887 | 38,900 | Put | Sole | 2020-05-13 | |
| 2020-03-31 | $1,636,859 | 17,261 | Shares | Sole | 2020-05-13 | |
| 2020-03-31 | $3,688,887 | 38,900 | Call | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||